Loading...
XTSX
PINK
Market cap18mUSD
Jul 11, Last price  
0.27CAD
1D
-1.85%
1Q
-39.77%
Jan 2017
194.44%
Name

Perimeter Medical Imaging AI Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
29.29
EPS
Div Yield, %
Shrs. gr., 5y
41.01%
Rev. gr., 5y
%
Revenues
846k
+109.70%
00000011,343132,766403,533846,194
Net income
-13m
L-29.30%
-291,733-4,832,6381,575,822705,669-10,498,653-8,003,014-16,762,080-3,585,976-18,944,198-13,393,928
CFO
-15m
L+0.18%
-89,890-61,451-79,640-131,588-5,785,153-8,262,987-13,912,389-11,867,905-14,696,253-14,723,023
Earnings
Aug 12, 2025

Profile

Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. was founded in 2013 and is headquartered in Toronto, Canada.
IPO date
Sep 02, 1988
Employees
Domiciled in
US
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
846
109.70%
404
203.94%
133
1,070.47%
Cost of revenue
19,186
18,108
15,790
Unusual Expense (Income)
NOPBT
(18,340)
(17,705)
(15,658)
NOPBT Margin
Operating Taxes
2
(6,320)
Tax Rate
NOPAT
(18,340)
(17,705)
(9,338)
Net income
(13,394)
-29.30%
(18,944)
428.29%
(3,586)
-78.61%
Dividends
Dividend yield
Proceeds from repurchase of equity
8,654
38,137
BB yield
-31.85%
-38.36%
Debt
Debt current
47
51
150
Long-term debt
228
335
381
Deferred revenue
206
96
272
Other long-term liabilities
Net debt
(5,909)
(18,048)
(27,908)
Cash flow
Cash from operating activities
(14,723)
(14,696)
(11,868)
CAPEX
(2,179)
(475)
(1,991)
Cash from investing activities
(1,900)
206
(1,749)
Cash from financing activities
8,582
234
40,284
FCF
(19,050)
(18,508)
(9,565)
Balance
Cash
6,184
18,434
28,439
Long term investments
Excess cash
6,142
18,414
28,432
Stockholders' equity
1,038
7,094
19,468
Invested Capital
9,760
13,135
7,236
ROIC
ROCE
EV
Common stock shares outstanding
71,494
64,671
60,616
Price
0.38
-68.85%
1.22
-25.61%
1.64
-60.00%
Market cap
27,168
-65.57%
78,899
-20.63%
99,410
-45.03%
EV
21,259
60,850
71,502
EBITDA
(17,611)
(17,090)
(14,857)
EV/EBITDA
Interest
26
105
Interest/NOPBT